Table 4.
Correlation of MAGEA3 protein expression and clinicopathological parameters.
| Clinicopathological factor | n | MAGEA3 protein | |
|---|---|---|---|
| Mean ± SEM | P | ||
| Age (year) | 0.816 | ||
| < 60 | 72 | 43.05 ± 1.569 | |
| ≥ 60 | 45 | 43.66 ± 2.137 | |
| Gender | 0.101 | ||
| Male | 47 | 45.82 ± 2.611 | |
| Female | 70 | 41.58 ± 1.151 | |
| Diameter | 0.6 | ||
| < 2 | 75 | 43.74 ± 1.635 | |
| ≥ 2 | 19 | 41.88 ± 2.771 | |
| Stage | 0.031 | ||
| < II | 83 | 41.55 ± 1.187 | |
| ≥ II | 34 | 47.52 ± 3.159 | |
| T | 0.11 | ||
| Tis + 1 | 82 | 42.41 ± 1.468 | |
| ≥ 2 | 28 | 47.28 ± 2.879 | |
| N | 0.283 | ||
| 0 | 81 | 42.38 ± 1.503 | |
| ≥ 1 | 36 | 45.33 ± 2.322 | |
| M | 0.863 | ||
| 0 | 97 | 43.18 ± 1.384 | |
| ≥ 1 | 20 | 43.77 ± 3.167 | |
| CEA | 0.922 | ||
| < 5 ng/ml | 85 | 43.51 ± 1.503 | |
| ≥ 5 ng/ml | 27 | 43.21 ± 2.685 | |
| NSE | 0.013 | ||
| < 16.3 ng/ml | 75 | 42.94 ± 1.455 | |
| ≥ 16.3 ng/ml | 9 | 55.52 ± 7.764 | |
Significant values are in bold.